NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA More...

Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Karyopharm Therapeutics (KPTI)

Technical Analysis Report for NASDAQ stock KPTI Karyopharm Therapeutics. Dated: 22 Nov 2024 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics then click here. or read Experts views on Karyopharm Therapeutics or Forecast & share price targets of Karyopharm Therapeutics

Karyopharm Therapeutics Opened at 0.77 and Closed at: 0.85, which is 8.24% of previous session's close. It moved within a range of 0.77 and 0.87
The session was a Bullish session with an average volume of 518300, which is 45.51% of previous session's volumes.

A Dead cross was found 5 days back on short term averages

Support for tomorrow is 0.81 and resistance for tomorrow is 0.91
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.79, 0.73 resistance for tomorrow's hourly charts is 0.89, 0.93

10 Day SMA for Karyopharm Therapeutics (KPTI) is 0.83 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Karyopharm Therapeutics (KPTI) is 0.86 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Karyopharm Therapeutics (KPTI) is 0.83 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 0.84 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Karyopharm Therapeutics is 1 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Karyopharm Therapeutics is at 0.86 and 200 DMA is at 1, while 50 DMA and 100 DMA are at 0.83 and 0.84 respectively

Karyopharm Therapeutics (KPTI) moving average of 20 SMA is at 0.86 and 20 EMA is at 0.83

Karyopharm Therapeutics (KPTI) moving average of 50 SMA is at 0.83 and 50 EMA is at 0.83

Karyopharm Therapeutics (KPTI) moving average of 100 SMA is at 0.84 and 100 EMA is at 0.95

Karyopharm Therapeutics (KPTI) moving average of 200 SMA is at 1 and 200 EMA is at 1.2

Karyopharm Therapeutics has performed better than Voyager Therapeutics in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Twist Bioscience has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 4.88% more returns!

Soleno Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Soleno Therapeutics, about 10.03% more returns!

Replimune Group has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Replimune Group, about 29.46% more returns!

Karyopharm Therapeutics has performed better than Optinose Inc in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Moleculin Biotech has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 9.76% more returns!

Karyopharm Therapeutics has performed better than Leap Therapeutics in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Karyopharm Therapeutics has performed better than Gossamer Bio in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Karyopharm Therapeutics has performed better than Fortress Biotech in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Ensign Group has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 1.93% more returns!

Champions Oncology has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 19.88% more returns!

Capnia Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Capnia Inc, about 5.66% more returns!

Apyx Medical has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 19.73% more returns!

Karyopharm Therapeutics has performed better than Aldeyra Therapeutics in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Karyopharm Therapeutics Technical analysis of indicators

Price action analysis of Karyopharm Therapeutics (KPTI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Karyopharm Therapeutics in short term but the sell signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Karyopharm Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Karyopharm Therapeutics in short term but BUY signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Karyopharm Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.84 and Karyopharm Therapeutics KPTI stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Karyopharm Therapeutics KPTI stock. Volume based technical analysis of Karyopharm Therapeutics KPTI stock is negative.

Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And KPTI Experts View which covers a lot of information including buying and selling signals

KPTI future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Karyopharm Therapeutics or View Candle Stick Charts here